ALEJANDRO ARROLIGA to Epoprostenol
This is a "connection" page, showing publications ALEJANDRO ARROLIGA has written about Epoprostenol.
Connection Strength
0.389
-
Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension. Drugs Today (Barc). 2004 Mar; 40(3):225-34.
Score: 0.224
-
Treatments and strategies to optimize the comprehensive management of patients with pulmonary arterial hypertension. Cleve Clin J Med. 2003 Apr; 70 Suppl 1:S18-27.
Score: 0.053
-
The prostacyclin analogue treprostinil blocks NFkappaB nuclear translocation in human alveolar macrophages. J Biol Chem. 2002 Sep 06; 277(36):33344-8.
Score: 0.050
-
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy. Lung. 2001; 179(4):233-43.
Score: 0.045
-
Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest. 2007 Apr; 131(4):984-7.
Score: 0.017